Company / Shares Outstanding
10x Genomics, Inc. Shares Outstanding History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
122.3M
FY2025
5-year range
108.5M / 122.3M
FY2021-FY2025
Trend
+2.7%
vs FY2024
Sector context
#72 of 165
Health Care
What the data says
At 122291837.00, 10x Genomics, Inc.'s shares outstanding ranks #94 of 165 in the Health Care sector. Shares Outstanding has increased for 8 consecutive years, from 11587751.00 in FY2017 to 122291837.00 in FY2025.
Based on SEC 10-K filings.
122291837.00 in FY2025 with a 5-year CAGR of +4.9%.
Increased from 115195009.00 to 122291837.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +2.8%
- 5-Year CAGR
- +4.9%
- 10-Year CAGR
- -
Sector benchmark
#94 of 165 in Health CareTop 56% of 165This company 122.3M Sector average 170.3M
▼
-28.2% below sector average
Key checks
Key Insights
- 10x Genomics, Inc.'s shares outstanding has grown for 8 consecutive years.
- In FY2025, shares outstanding increased 2.7% year-over-year.
- Ranks #72 out of 165 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 122.3M | +2.7% |
| FY2024 | 119.1M | +3.4% |
| FY2023 | 115.2M | +2.4% |
| FY2022 | 112.5M | +3.7% |
| FY2021 | 108.5M | +12.7% |
| FY2020 | 96.2M | +561.5% |
| FY2019 | 14.5M | +8.6% |
| FY2018 | 13.4M | +15.6% |
| FY2017 | 11.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026